Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes

AIMS: Wolfram syndrome (WFS) is diagnosed as coexistence of diabetes mellitus and optic atrophy, where pancreatic beta cell destruction is associated with neurodegeneration. Typically, WFS necessitates insulin treatment similar to type 1 diabetes (T1D), but the mechanism of beta cell mass reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Zmyslowska, A., Fendler, W., Szadkowska, A., Borowiec, M., Mysliwiec, M., Baranowska-Jazwiecka, A., Buraczewska, M., Fulmanska-Anders, M., Mianowska, B., Pietrzak, I., Rzeznik, D., Mlynarski, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628085/
https://www.ncbi.nlm.nih.gov/pubmed/25916214
http://dx.doi.org/10.1007/s00592-015-0757-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628085/
https://www.ncbi.nlm.nih.gov/pubmed/25916214
http://dx.doi.org/10.1007/s00592-015-0757-5

Ejemplares similares